244
Participants
Start Date
June 15, 2021
Primary Completion Date
December 15, 2021
Study Completion Date
December 15, 2021
QazCoVac-P -COVID-19 Subunit Vaccine
QazCoVac-P (Subunit) Vaccine manufactured by Research Institute for Biological Safety Problems Republic of Kazakhstan
Placebo
The use of placebo: intramuscularly, twice, spaced 21 days apart, at a dose of 0.5 ml (22 volunteers)
Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, Gvardeyskiy
Research Institute for Biological Safety Problems
OTHER_GOV